Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer’s disease

Apr 3

Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer's disease - Chiu et al. 2013

Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer's disease

Publication Date: 2015.07.23

Authors: M. J. Chiu, S. Y. Yang, H. E. Horng, C. C. Yang, T. F. Chen, J. J. Chieh, H. H. Chen, T. C. Chen, C. S. Ho, S. F. Chang, H. C. Liu, C. Y. Hong, H. C. Yang

Journal: ACS Chem. Neurosci. 4(12): 1530-1536 (2013)

Authors

M. J. Chiu

S. Y. Yang

H. E. Horng

C. C. Yang

T. F. Chen

J. J. Chieh

H. H. Chen

T. C. Chen

C. S. Ho

S. F. Chang

H. C. Liu

C. Y. Hong

H. C. Yang

Citation

M. J. Chiu, S. Y. Yang, H. E. Horng, C. C. Yang, T. F. Chen, J. J. Chieh, H. H. Chen, T. C. Chen, C. S. Ho, S. F. Chang, H. C. Liu, C. Y. Hong, H. C. Yang, "Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer's disease", ACS Chem. Neurosci. 4(12): 1530-1536 (2013).

Yiran Gan

Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer’s disease

Authors

Citation

Plasma tau as a window to the brain-negative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease

Development for high-accuracy in-vitro assay of vascular endothelial growth factor using nano-magnetically labeled immunoassay